What is Big Think?  

We are Big Idea Hunters…

We live in a time of information abundance, which far too many of us see as information overload. With the sum total of human knowledge, past and present, at our fingertips, we’re faced with a crisis of attention: which ideas should we engage with, and why? Big Think is an evolving roadmap to the best thinking on the planet — the ideas that can help you think flexibly and act decisively in a multivariate world.

A word about Big Ideas and Themes — The architecture of Big Think

Big ideas are lenses for envisioning the future. Every article and video on bigthink.com and on our learning platforms is based on an emerging “big idea” that is significant, widely relevant, and actionable. We’re sifting the noise for the questions and insights that have the power to change all of our lives, for decades to come. For example, reverse-engineering is a big idea in that the concept is increasingly useful across multiple disciplines, from education to nanotechnology.

Themes are the seven broad umbrellas under which we organize the hundreds of big ideas that populate Big Think. They include New World Order, Earth and Beyond, 21st Century Living, Going Mental, Extreme Biology, Power and Influence, and Inventing the Future.

Big Think Features:

12,000+ Expert Videos


Browse videos featuring experts across a wide range of disciplines, from personal health to business leadership to neuroscience.

Watch videos

World Renowned Bloggers


Big Think’s contributors offer expert analysis of the big ideas behind the news.

Go to blogs

Big Think Edge


Big Think’s Edge learning platform for career mentorship and professional development provides engaging and actionable courses delivered by the people who are shaping our future.

Find out more

Private Ownership of Genetic Data May Undermine Diagnoses

November 3, 2012, 4:00 PM

What's the Latest Development?

The European Society of Human Genetics is crying foul over an American company's insistence at keeping large stores of genetic information private. The company, Myriad Genetics, does not share the data it has amassed on variants of unknown significance (VUS) with public institutions. "By not sharing their data on the VUS obtained from individuals undergoing BRCA1/2 testing, where Myriad is the sole commercial provider of a test in the U.S., geneticists have been unable to develop the up-to-date algorithms that are necessary to best interpret the effects of genetic variants."

What's the Big Idea?

The European organization argues that while Myriad currently benefits from data made public by government institutions, that relationship is not reciprocal, and without sharing data, the company may find it more difficult gaining access to European markets. "It is vital that progress towards personalized medicine, which holds out so much promise, is not hindered by companies maintaining private genomic databases," said the organization. The VUS that may be found in an individual's genome may be used to provide proper genetic counselling and if necessary, preventive or therapeutic guidance.

Photo credit: Shutterstock.com


Private Ownership of Geneti...

Newsletter: Share: